Related Experiment Video
Updated: Jan 23, 2026

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
Published on: August 11, 2017
Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters
Jürg Oliver Straub1, Rik Oldenkamp2,3, Thomas Pfister1
1Group Safety, Health, and Environmental Protection, F.Hoffmann-La Roche, Basle, Switzerland.
Abstract:
An environmental risk assessment is presented for mycophenolic acid (MPA), an immunosuppressive pharmaceutical used for prevention of organ rejection, and its prodrug mycophenolate mofetil (MPM). Mycophenolic acid will not significantly adsorb to activated sludge. In activated sludge, 14 C-MPA attained >80% degradation, supporting an older environmental fate test with the same compound. Based on n-octanol/water distribution coefficient (log DOW ) values of 2.28, 0.48, and ≤-1.54 at pH 5, 7, and 9, respectively, MPA is not expected to bioaccumulate. Sales amounts of MPA+MPM in Europe were used to derive predicted environmental concentrations (PECs) in surface waters; PECs were refined by including expected biodegradation in sewage treatment, average drinking water use, and average dilution of the effluents in the receiving waters per country. In addition, the exposure to pharmaceuticals in the environment (ePiE) model was run for 4 European catchments. The PECs were complemented with 110 measured environmental concentrations (MECs), ranging from below the limit of quantitation (<0.001 µg/L) to 0.656 µg/L. Predicted no-effect concentrations (PNECs) were derived from chronic tests with cyanobacteria, green algae, daphnids, and fish. The comparison of PECs and MECs with the PNECs resulted in a differentiated environmental risk assessment in which the risk ratio of PEC/PNEC or MEC/PNEC was <1 in most cases (mostly >90%), meaning no significant risk, but a potential risk to aquatic organisms in generally <10% of instances. Because this assessment reveals a partial risk, the following questions must be asked: How much risk is acceptable? and Through which measures can this risk be reduced? These questions are all the more important in view of limited alternatives for MPM and MPA and the serious consequences of not using them. Environ Toxicol Chem 2019;38:2259-2278. © 2019 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals, Inc. on behalf of SETAC.
Insights
Environmental risk assessment for mycophenolic acid (MPA) and mycophenolate mofetil (MPM) shows low risk to aquatic organisms. While generally safe, a small percentage of instances indicate potential risks requiring further evaluation and mitigation strategies.
Area of Science:
- Environmental toxicology and chemistry
- Pharmaceutical risk assessment
- Ecotoxicology
Background:
- Mycophenolic acid (MPA) and its prodrug mycophenolate mofetil (MPM) are crucial immunosuppressants for organ transplant recipients.
- Understanding the environmental fate and ecotoxicological impact of these widely used pharmaceuticals is essential.
Purpose of the Study:
- To conduct a comprehensive environmental risk assessment for MPA and MPM in European surface waters.
- To determine predicted environmental concentrations (PECs) and compare them with predicted no-effect concentrations (PNECs) for aquatic organisms.
Main Methods:
- Environmental fate assessment including adsorption to activated sludge and biodegradation of MPA.
- Bioaccumulation potential evaluation using n-octanol/water distribution coefficients (log DOW).
- PEC derivation using sales data, sewage treatment biodegradation, and dilution factors; supplemented with measured environmental concentrations (MECs).
- Ecotoxicity testing on cyanobacteria, algae, daphnids, and fish to derive PNECs.
Main Results:
- MPA showed limited adsorption to activated sludge and significant degradation (>80%).
- MPA is not expected to bioaccumulate based on log DOW values across different pH levels.
- PECs and MECs were mostly below PNECs (in >90% of cases), indicating no significant environmental risk.
- A potential risk to aquatic organisms was identified in a small percentage (<10%) of instances.
Conclusions:
- The environmental risk assessment indicates a generally low risk associated with MPA and MPM.
- However, a partial risk necessitates further investigation into acceptable risk levels and potential mitigation measures.
- Given the therapeutic importance and limited alternatives, balancing risks and benefits is crucial.
More Related Videos
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
08:07A Two-Step Pyrolysis-Gas Chromatography Method with Mass Spectrometric Detection for Identification of Tattoo Ink Ingredients and Counterfeit Products
Published on: May 22, 2019
Related Concept Videos
Water: A Bronsted-Lowry Acid and Base
Pharmaceutical Equivalents
Water and Mineral Acquisition
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Relative Risk
Acid–Base Equilibria: Activity-Based Definition of pH
In solutions of very low ionic strength—for example, pure water—the...